We understand that some people may be concerned about getting vaccinated once a COVID-19 vaccine is available.
Post
Post
WHO recommendation COVID-19 mRNA vaccine (nucleoside modified) – COMIRNATY
Comirnaty, COVID-19 mRNA vaccine (nucleoside modified) is a vaccine for preventing coronavirus disease 2019 (COVID-19) in individuals aged 16 years and older
Post
A Close-up of COVID-19 in Lung Cells
This image offers a striking example of exactly what happens to cells in the human airway when this coronavirus infects them.
Post
European Medicines Agency recommends first COVID-19 vaccine for authorisation in the EU
European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for the vaccine Comirnaty - developed by BioNTech/Pfizer
Post
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
The FDA’s authorization for emergency use of the first COVID-19 vaccine
Post
Health Canada decision issued: Pfizer-BioNTech COVID-19 Vaccine was authorized for use in relation to the COVID-19 pandemic
Health Canada analysis of known and potential benefits and known and potential risks
Post
Understanding mRNA COVID-19 Vaccines
mRNA vaccines are a new type of vaccine to protect against infectious diseases
Post
Understanding How COVID-19 Vaccines Work
The Immune System—The Body’s Defense Against Infection
Post
COVID-19 vaccine myths debunked
A vaccine to prevent coronavirus disease 2019 (COVID-19) is perhaps the best hope for ending the pandemic.
Post
COVID-19: Herd immunity and lockdowns
Understand what's known about herd immunity and what it means for coronavirus disease 2019 (COVID-19).